News Releases

Toronto,Ontario. – January 26, 2006 – Paving the way for its entry into the molecular imaging market, VisualSonics, the world’s leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, today announced that it is in-licensing a contrast agent for the quantification of myocardial perfusion in preclinical studies from the University of Virginia.

Toronto, Ontario – January 23, 2006 – VisualSonics, the world’s leading developer of high resolution, micro-ultrasound-based in vivo imaging systems for preclinical research, today announced that its quality management system has been registered as complying with the requirements of ISO 9001:2000.

PARIS and TORONTO - March 31st, 2009 – Mauna Kea Technologies and VisualSonics today announced that they have entered an exclusive distribution agreement through which VisualSonics will market and sell Cellvizio LAB high resolution in vivo imaging systems to pre-clinical researchers on a worldwide basis.

TORONTO, Canada – October 16, 2009 – TORONTO, Canada – October 16, 2009 - VisualSonics Inc., a leader in real time, in vivo, high-resolution micro imaging systems, today introduced the NeuroPak™ Deep Brain Imaging System. NeuroPak™ is a novel technology that provides pre-clinical neurology researchers with the capability to image biological and cellular processes in the brains of conscious animals. Read more.

TORONTO, Canada - April 14, 2010 – VisualSonics Inc and Bracco Group today announced the launch of VevoCQ™ Advanced Quantification Software Tools for the Vevo® 2100 linear array based high-frequency ultrasound imaging system.

BOTHELL, WA- May 27, 2010 – SonoSite, Inc. (NASDAQ: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that it has signed an agreement to acquire privately held VisualSonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology.

BOTHELL, WA- June 30, 2010 – SonoSite, Inc. (NASDAQ: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that on June 30, 2010, it completed its acquisition of privately held VisualSonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology, for $67.9 million net of cash and debt.

TORONTO, Canada – April 4, 2011 – VisualSonics Inc., a leader in real time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., (Nasdaq:Sono), is demonstrating the recently announced Vevo® LAZR Photoacoustics Imaging system at the American Association of Cancer Research’s annual conference (April 2-6, 2011, Orlando, FL).

TORONTO, Canada – April 14, 2011 - VisualSonics Inc., a leader in real-time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., announced today that its VevoStrain™ technology has been featured on the cover of the April 15th, 2011 issue of Circulation Research, Journal of the American Heart Association.

TORONTO, Canada –October 10, 2013 - Using high-frequency ultrasound and special cardiac-assessment software by FUJIFILM VisualSonics, Inc., researchers have been able to implant engineered stem cells into the damaged heart tissue of mice and, over time, observe the regeneration of healthy cardiac rhythms.